Sydney Lepkin
👤 SpeakerAppearances Over Time
Podcast Appearances
Novo Nordisk has been working on a pill containing the same active ingredient as Ozempic and Wegovi.
It's a higher dose than what's in type 2 diabetes pill Rebelsis and is instead aimed at patients with obesity.
Studies show the new pill's efficacy is similar to Wagovi's.
If approved, the company says it will offer a discounted price of $149 a month for people not using their health insurance.
That's part of a deal announced with the Trump administration earlier this year.
Novo Nordisk has not yet announced a sticker price for insurers yet, however.
And that is the price that will determine insurance coverage.
The company says it is working with other parts of the drug supply chain to improve access.
The new restructuring plan replaces one the Supreme Court rejected in 2024, finding that it would have shielded the Sackler family from future lawsuits.
This time around, members of the family can still be sued in civil court.
The Sackler family will pay up to $7 billion to Purdue's creditors as part of the plan.
The arrangement will also provide a pool of up to $865 million to compensate individual victims.
The plan was approved by Judge Sean Lane of the United States Bankruptcy Court for the Southern District of New York.
Purdue will dissolve and emerge as a new company, Noah Pharma.
Its focus will include overdose reversal medicines, and it will not involve the Sacklers.
The new restructuring plan replaces one the Supreme Court rejected in 2024, finding that it would have shielded the Sackler family from future lawsuits.
This time around, members of the family can still be sued in civil court.